Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of an Innovative Glycomacropeptide Based Protein Supplement Purified to Lower the Phenylalanine Content for the Treatment of Paediatric Patients With Phenylketonuria

NCT06332105 is registered in ClinicalTrials.gov with Ajinomoto Co., Inc. as lead sponsor.

NCT NCT06332105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06332105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of an Innovative Glycomacropeptide Based Protein Supplement Purified to Lower the Phenylalanine Content for the Treatment of Paediatric Patients With Phenylketonuria
Lead sponsor
Ajinomoto Co., Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2023
Completion date
April 30, 2025
Enrollment
19 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonurias